Twist Bioscience has around 494 employees in the Bay Area, according to LinkedIn. While the majority of the company is based in the Bay Area, it also maintains a manufacturing facility in Wilsonville, Oregon. Headquartered in South San Francisco, Twist Bioscience manufactures synthetic DNA and produced its first product this year. SOPA Images/SOPA Images/LightRocket via Getty Images “While this was a difficult decision, it was the right one for Twist and sets us up for long term success on a path to profitability, operating more efficiently while still continuing to support our high growth focus areas, continuing to serve our customers who are improving health and sustainability,” a Twist spokesperson said in a statement sent to SFGATE.įile: A Twist Bioscience logo seen displayed on a smartphone. The company declined to comment on whether these cuts would affect the company's current real estate holdings. Learn more about Greater Portland's growing health sciences and tech sector online.About three-fourths of the layoffs are Bay Area employees, some of whom work remotely, a Twist Bioscience spokesperson told SFGATE. Jeff Reardon, the office of Multnomah County Commissioner Lori Stegmann, GPI’s economic development practitioner network, and the office of Oregon Gov. This announcement is the culmination of months of work with the following partners to recruit Twist to the region: The City of Wilsonville, Oregon Bioscience Association, Business Oregon, the office of Oregon State Rep. “The Portland area is an established technology hub relatively close in proximity to our headquarters with a growing number of biotechnology companies, providing access to talent and advanced manufacturing to increase the speed of production and deliver products to our customers faster,” said Twist CEO and Co-founder Emily M. Meanwhile, OHSU continues to drive modern medical discovery with its groundbreaking work in oncology and gene editing. Global biotech leader Genentech in 2018 doubled down on its investment in the region with a new 300-person office in Portland to support its operations facility in Hillsboro. Twist’s 110,000-square-foot facility in Wilsonville is expected to become operational in 2022, and will further solidify Greater Portland’s growing reputation as a hub for firms at the forefront of cutting-edge biotechnology innovation. Applications of this unique technology include synthetic genes, tools for next-generation sequencing preparation, and antibody libraries for drug discovery and development. Twist, based in San Francisco, is a synthetic biology and genomics company whose proprietary technology enables it to manufacture synthetic DNA by “writing” the DNA on a silicon chip. This marks GPI’s largest business recruitment project to date, in terms of jobs, and it shows that the region remains an attractive investment even in the midst of a global pandemic. Greater Portland Inc is excited to announce that Twist Bioscience is building a “Factory of the Future” in Wilsonville, adding as many as 400 jobs to Greater Portland. Twist Bioscience's 'Factory of the Future' in Wilsonville to Add 400 Jobs
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |